Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Roper entered the second half of 2026 with solid operating momentum: second-quarter revenue increased 9%, organic revenue increased 5%, adjusted diluted EPS increased 10% and adjusted free cash flow increased 11%. Management raised its full-year adjusted diluted EPS range to $22.15-$22.30 and its organic-growth outlook to approximately 6%. These strengths are balanced by a 130-basis-point year-over-year decline in adjusted EBITDA margin, execution dependence on continued product innovation and acquisitions. The resulting stance is Hold rather than an unqualified Buy.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets15 analysts · as of 18 Aug 2026
Low · most bearish analyst$335.00
Mean target$445.20
High · most bullish analyst$550.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$340.0018%

Organic growth falls below 5%, adjusted free cash flow loses year-over-year momentum, or management reduces the low end of adjusted diluted EPS guidance below $22.15. Margin compression, acquisition integration challenges, cybersecurity events or weaker demand for mission-critical products would amplify downside. The price target is an internal scenario estimate rather than an externally anchored consensus.

Base CaseCentral scenario
$445.2059%
Matches the consensus mean

Roper delivers near its raised $22.15-$22.30 adjusted diluted EPS guidance, organic growth finishes near the approximately 6% outlook, and free cash flow remains resilient, while margin pressure and execution risk limit valuation expansion.

Bull CaseUpside scenario
$560.0023%

Organic growth reaches or exceeds the approximately 6% full-year outlook, adjusted free cash flow continues growing at a double-digit rate, margins stabilize, and recently launched AI products expand addressable markets and customer value. Successful acquisition deployment would provide an additional upside path.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Second-quarter 2026 revenue increased 9%, including 5% organic growth, demonstrating continued demand for Roper's mission-critical software and technology-enabled products.
  • Adjusted free cash flow increased 11% year over year to $447 million in the second quarter, supporting continued reinvestment and shareholder-value creation.
  • Management raised full-year 2026 adjusted diluted EPS and organic-growth guidance while reporting multiple new AI product launches across the portfolio.
Sign in / Sign up to read more
Key Investment Risks
  • Second-quarter adjusted EBITDA margin declined to 38.6% from 39.9%, a 130-basis-point year-over-year contraction.
  • Management identifies acquisition execution, artificial-intelligence development, cybersecurity, data privacy, regulation and macroeconomic conditions among factors that could cause results to differ from expectations.
  • Published guidance excludes unannounced acquisitions or divestitures, pending Indicor transaction proceeds and potential additional share repurchases, increasing uncertainty around future per-share outcomes.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.